Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/24/2026 | Q1 | $7.1B | -- | -- | $1.41 | -- |
| 12/02/2025 | Q4 | $6.7B | $13B | $1.19 | $1.31 | -$0.12 |
| 08/26/2025 | Q3 | $6.7B | $12.9B | $1.34 | $1.25 | $0.09 |
| 05/27/2025 | Q2 | $6.5B | $12.5B | $1.04 | $1.12 | -$0.08 |
| 02/25/2025 | Q1 | $6.2B | $13.2B | $0.47 | $1.17 | -$0.71 |
| 12/03/2024 | Q4 | $6.2B | $13.7B | $0.90 | $1.14 | -$0.25 |
| 08/27/2024 | Q3 | $6.3B | $13.8B | $1.03 | $1.20 | -$0.17 |
| 05/28/2024 | Q2 | $6.1B | $13.7B | $1.16 | $1.14 | $0.02 |
| 02/27/2024 | Q1 | $6.1B | $13.9B | $1.24 | $1.20 | $0.05 |
| 11/28/2023 | Q4 | $6B | $13.6B | $0.74 | $1.20 | -$0.47 |
| 08/29/2023 | Q3 | -- | $13.4B | $1.29 | -- | -- |
| 05/24/2023 | Q2 | -- | $12.6B | $1.24 | -- | -- |
| 02/28/2023 | Q1 | -- | $12.2B | $1.00 | -- | -- |
| 11/29/2022 | Q4 | -- | $10.7B | $1.19 | -- | -- |
| 08/23/2022 | Q3 | -- | $9.1B | $1.62 | -- | -- |
| 05/25/2022 | Q2 | -- | $8.1B | $1.71 | -- | -- |
| 03/01/2022 | Q1 | -- | $7.8B | $1.67 | -- | -- |
| 11/30/2021 | Q4 | -- | $7.5B | $1.57 | -- | -- |
| 08/24/2021 | Q3 | -- | $7.6B | $1.62 | -- | -- |
| 06/01/2021 | Q2 | -- | $7.5B | $1.50 | -- | -- |
| 02/23/2021 | Q1 | -- | $7.7B | $1.45 | -- | -- |
| 12/01/2020 | Q4 | -- | $7.3B | $1.07 | -- | -- |
| 08/25/2020 | Q3 | -- | $7.5B | $0.76 | -- | -- |
| 05/26/2020 | Q2 | -- | $8.1B | $0.73 | -- | -- |
| 02/25/2020 | Q1 | -- | $8.9B | $1.39 | -- | -- |
| 11/26/2019 | Q4 | -- | $8.7B | $1.29 | -- | -- |
| 08/27/2019 | Q3 | -- | $8.6B | $1.13 | -- | -- |
| 05/28/2019 | Q2 | -- | $8.5B | $1.30 | -- | -- |
| 02/26/2019 | Q1 | -- | $8.5B | $1.29 | -- | -- |
| 11/27/2018 | Q4 | -- | $8.2B | $1.32 | -- | -- |
| 08/28/2018 | Q3 | -- | $8B | $1.19 | -- | -- |
| 05/29/2018 | Q2 | -- | $7.6B | $1.33 | -- | -- |
| 02/27/2018 | Q1 | -- | $7.7B | $1.47 | -- | -- |
| 11/28/2017 | Q4 | -- | $7.7B | $1.31 | -- | -- |
| 08/29/2017 | Q3 | -- | $7B | $1.26 | -- | -- |
| 05/30/2017 | Q2 | -- | $6.6B | $1.22 | -- | -- |
| 02/28/2017 | Q1 | -- | $6.8B | $1.18 | -- | -- |
| 11/29/2016 | Q4 | -- | $6.6B | $1.20 | -- | -- |
| 08/30/2016 | Q3 | -- | $6.7B | $1.19 | -- | -- |
| 05/31/2016 | Q2 | -- | $6.6B | $0.93 | -- | -- |
| 03/01/2016 | Q1 | -- | $6B | $1.04 | -- | -- |
The Bank of Nova Scotia reported $13B worth of top line sales in its most recent quarter.
The Bank of Nova Scotia announced earnings per share of $1.19 which represents a miss of analyst forecast a $1.31 per share.
The Bank of Nova Scotia reported -- that represents -- per share over the last quarter.
The Bank of Nova Scotia's earnings are forecast to grow from $4.05 per share to $4.97 per share next year representing an increase of 43.94%.
The Bank of Nova Scotia's next earnings date is February 24, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.